Helix

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results

Retrieved on: 
Wednesday, March 27, 2024
Research, Finkelstein, Arrhythmia, Stroke, Annual report, Certification, Myocardial infarction, BCDA, Partnership, Patient, The Study, Morph, Mortality, Form 10-K, Security (finance), Death, Heart transplantation, Quality of life, Doctor of Philosophy, Heart failure, Therapy, Heart, Safety, Data, Medicare, FDA, Helix, Arrest, Hospital, Pharmaceutical industry

The Company will also hold a conference call at 4:30 PM ET today in which it will discuss business highlights with call details below.

Key Points: 
  • The Company will also hold a conference call at 4:30 PM ET today in which it will discuss business highlights with call details below.
  • The Company anticipates completing follow-up in the trial and preparing this dataset on 115 randomized patients enrolled with a minimum of one-year follow-up for final lock in the fourth quarter of 2024.
  • BioCardia has had discussions on partnering its CardiAMP therapy for other clinical indications and continues to explore partnerships worldwide.
  • All callers should dial in approximately 10 minutes prior to the scheduled start time and ask to be joined into the BioCardia call.

Helix Announces First Quarter Earnings Release Date and Conference Call Information

Retrieved on: 
Friday, April 5, 2024
Robotics, Other Energy, Technology, Oil, Gas, Alternative Energy, Energy, Staffeldt, Helix Energy Solutions Group, Webcast, HLX, Helix, Central Time

Helix Energy Solutions Group, Inc. (NYSE: HLX) will issue a press release reporting its first quarter 2024 results on Wednesday, April 24, 2024, after the close of business.

Key Points: 
  • Helix Energy Solutions Group, Inc. (NYSE: HLX) will issue a press release reporting its first quarter 2024 results on Wednesday, April 24, 2024, after the close of business.
  • The press release and associated slide presentation will be available on Helix's website, www.helixesg.com .
  • Helix will review its first quarter 2024 results on Thursday, April 25, 2024, at 9:00 a.m. Central Time via a live webcast and teleconference.
  • The live webcast will be available on our website under "For the Investor."

North America Molecular Diagnostics Market Size, Share & Trends Analysis Report 2024-2030: Growing Prevalence of Target Diseases & Increasing External Funding for R&D Fueling Expansion - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 26, 2024
Health, Biotechnology, Candidiasis, Diagnosis, PCR, MVP, Conditional sentence, Bacterial vaginosis, Prevalence, Infection, Promega, Country, Thermo Fisher Scientific, SME, Tuberculosis, Application, ISH, RT, HIV, Alzheimer's disease, Incidence, Turner syndrome, Cepheid variable, Research, Trichomoniasis, Real-time, Cancer, Death, Parkinson's disease, CDC, QIAGEN, Therapy, USD, Horvitz–Thompson estimator, Helix, DSM-IV codes, Vaccine

Advancements in molecular diagnostic technology enabled the early detection of numerous diseases and reduced the possibility of severe economic & social burdens.

Key Points: 
  • Advancements in molecular diagnostic technology enabled the early detection of numerous diseases and reduced the possibility of severe economic & social burdens.
  • Molecular diagnostics enable early diagnosis of cancer, genetic disorders, and infectious diseases by using PCR, sequencing, & genetic technologies.
  • In addition, the increasing incidence of diseases, such as influenza A & B, is projected to drive market growth.
  • An increase in external funding to conduct clinical studies in molecular diagnostics is anticipated to fuel the market.

Soluna’s Project Dorothy 2 Prepares to Deliver $14M in Potential Operating Profit

Retrieved on: 
Thursday, March 14, 2024
Hardware, Commercial Building & Real Estate, Alternative Energy, Security, Construction & Property, Data Management, Energy, Sustainability, Technology, Blockchain, Professional Services, Environment, Artificial Intelligence, Other Technology, Cryptocurrency, Bitcoin, Carbon, Annual report, Project, Renewable resource, AI, Security (finance), Carbon footprint, GAAP, Multimedia, Compulsion, Shovel ready, Helix

John Belizaire, CEO of Soluna Holdings, commented, “Through our experience successfully energizing our 50 MW first phase of Project Dorothy, we have a blueprint to bring Project Dorothy 2 online faster and more efficiently.

Key Points: 
  • John Belizaire, CEO of Soluna Holdings, commented, “Through our experience successfully energizing our 50 MW first phase of Project Dorothy, we have a blueprint to bring Project Dorothy 2 online faster and more efficiently.
  • According to the company’s financial modeling, Project Dorothy 2 has the potential to generate up to $14 million of additional annualized project-level operating profits1 for the Company in Bitcoin Hosting revenue.
  • Low Carbon Footprint - In late August 2023, the Company completed the construction and fully ramped Project Dorothy 1.
  • To date, Soluna has received several proposals for financing Project Dorothy 2 and is close to completing diligence.

Promising New Data Published on Potential Therapy to Boost Effectiveness of Pancreatic Cancer Treatments

Retrieved on: 
Tuesday, March 26, 2024
Toxicity, Cell, Development, Survival, BLR, Disease, American Cancer Society, PNAC, Research, University, Quality of life, Cancer, IND, Pharmacology, Pancreatic cancer, Mario, Potential, RFU, Therapy, Helix, Person, Pharmaceutical industry

The data points to a promising strategy to boost the effectiveness of existing drugs in pancreatic cancer and other solid-tumor cancers.

Key Points: 
  • The data points to a promising strategy to boost the effectiveness of existing drugs in pancreatic cancer and other solid-tumor cancers.
  • According to the American Cancer Society , some 66,000 persons in the U.S. are diagnosed annually with pancreatic cancer, a disease with a very low survival rate that is projected to take 51,000 lives in 2024.
  • "Finding an approach to use lower doses while maintaining efficacy has been a constant search for cancer treatments."
  • "BLR-100 targets the formation of the protective tumor stroma, a fibrotic-like element that is thought to retard the entry of chemo-therapeutic agents."

RTA Deploys Fiber-To-The-Premises with DZS Technology to Bring World-Class Broadband Experience to Texas’ Bolivar Peninsula

Retrieved on: 
Monday, March 4, 2024
Cloud, ONT, FWA, RTA, PON, INTERNET, Human, Fiber to the x, BABA, FTTH, Digital divide, Helix

RTA, which manages more than 13,000 fiber route miles across its 22-state footprint, is upgrading targeted fixed wireless access (FWA) networks to state-of-the-art fiber-to-the-premises (FTTx) access networks.

Key Points: 
  • RTA, which manages more than 13,000 fiber route miles across its 22-state footprint, is upgrading targeted fixed wireless access (FWA) networks to state-of-the-art fiber-to-the-premises (FTTx) access networks.
  • By upgrading its Bolivar Peninsula network to DZS solutions, RTA will be the first to bring fiber-to-the-home (FTTH) and multi-gigabit speeds to more than 6,000 residential and business customers in the region.
  • “DZS is the ideal partner to help us to continue delivering on our mission to bring gigFAST INTERNET communications services to rural communities across America,” said Donald Workman, Chief Operating Officer, RTA.
  • DZS solutions are standards-based, have proven interoperability with most vendors’ equipment and can be readily managed and orchestrated alongside third-party solutions.

The RealReal Names Ajay Gopal as its Chief Financial Officer and Appoints Karen Katz as Chairperson of its Board of Directors

Retrieved on: 
Wednesday, February 21, 2024
CFO, Acquisition, SAN, Neiman Marcus, The RealReal, StubHub, Chairperson, Ajay, Attention, GE HealthCare, Management, EBay, Mytheresa, Helix, E-commerce

“I’m thrilled to welcome Ajay to The RealReal,” said John Koryl, The RealReal’s Chief Executive Officer.

Key Points: 
  • “I’m thrilled to welcome Ajay to The RealReal,” said John Koryl, The RealReal’s Chief Executive Officer.
  • Mr. Gopal has proven his strategic ability to leverage finance organizations to help drive profitable growth.
  • "Over the past few years, resale has gained significant momentum and attention from consumers as well as investors," said Mr. Gopal.
  • On the appointment of Ms. Katz as Chairperson of the board, Mr. Koryl continued, “Karen has made immeasurable contributions to The RealReal since she joined the Board in 2021.

Helix Secures Deepwater Well Intervention Contract Offshore Nigeria

Retrieved on: 
Monday, February 26, 2024
Alternative Energy, Energy, Other Energy, Oil, Gas, Safety, Helix Energy Solutions Group, Helix, HLX, IRS, Esso

Helix Energy Solutions Group, Inc. (NYSE: HLX) is pleased to announce a deepwater well intervention contract award by Esso Exploration and Production Nigeria (Deepwater) Ltd. (“Esso”).

Key Points: 
  • Helix Energy Solutions Group, Inc. (NYSE: HLX) is pleased to announce a deepwater well intervention contract award by Esso Exploration and Production Nigeria (Deepwater) Ltd. (“Esso”).
  • The project, located offshore Nigeria in the Erha and Usan fields, is expected to commence in September 2024 with the vessel expected to be in Nigeria into 2025.
  • The fields are located approximately 97km offshore of Nigeria in water depths ranging from 700m to 1,500m.
  • Under the contract, Helix will provide the Q4000, a DP3 riser-based semi-submersible well intervention vessel, a 10k Intervention Riser System (IRS), remotely operated vehicles, project management, and engineering services to cover fully integrated well intervention services from production enhancement to plug and abandonment.

Altria Group, Inc. Announces Retirement of Director Jacinto J. Hernandez From Board of Directors

Retrieved on: 
Monday, February 26, 2024
Tobacco, Retail, Investment, FDA, Food, NJOY, Marketing, Capital Group Companies, MST, Vision, Heated tobacco product, ARIS, PXD, AB InBev, PM, ABI, Helix, Pioneer Natural Resources, Horizon, Smoker

Jacinto J. Hernandez, a director of Altria Group, Inc. (“Altria”), retired from service on our Board of Directors effective February 23, 2024.

Key Points: 
  • Jacinto J. Hernandez, a director of Altria Group, Inc. (“Altria”), retired from service on our Board of Directors effective February 23, 2024.
  • Mr. Hernandez will continue to serve Altria as a strategic advisor under a 5-year advisory services agreement.
  • "We thank Jacinto for his service on our Board," said Kathryn McQuade, Altria’s independent Board Chair.
  • Trademarks related to Altria referenced in this release are the property of Altria or our subsidiaries or are used with permission.

Altria Presents as Part of the Consumer Analyst Group of New York Conference; Reaffirms 2024 Full-Year Earnings Guidance

Retrieved on: 
Wednesday, February 21, 2024
Agriculture, Natural Resources, Other Retail, Finance, Tobacco, Professional Services, Other Natural Resources, Retail, Artificial intelligence, Investment, NPM, Growth, Sale, JUUL, Pandemic, MST, Health, Climate change, Private sector, Webcast, Smoker, MSA, Marketing, GAAP, Uncertainty, EPS, Juul, Law enforcement, Information, Conference, Heated tobacco product, AB InBev, PM, Horizon, Acquisition, Annual report, Climate, FDA, Food, NJOY, Risk, Vision, Privacy, Helix

Altria Group, Inc. (Altria) (NYSE: MO) is participating in the Consumer Analyst Group of New York Conference in Boca Raton, Florida today.

Key Points: 
  • Altria Group, Inc. (Altria) (NYSE: MO) is participating in the Consumer Analyst Group of New York Conference in Boca Raton, Florida today.
  • A copy of the business presentation, prepared remarks and a replay of the webcast will be available at www.altria.com .
  • We expect 2024 adjusted diluted EPS growth to be weighted to the second half of the year.
  • While the 2024 full-year adjusted diluted EPS guidance accounts for a range of scenarios, the external environment remains dynamic.